Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 38051-38100 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06639542
Sexual Agency of Women Who Have Suffered from Incest(s)
N/ARecruiting
10 participants
Started: Oct 14, 2024 · Completed: Apr 20, 2025
5 conditions1 sponsor1 location
NCT06637241
Risk Stratification Care for Injury Prevention in Taiwan Adolescent Baseball Players
NANot yet recruiting
636 participants
Started: Oct 14, 2024 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT06632080
Effects of Substance P on Headache Induction in Healthy Individuals
NANot yet recruiting
21 participants
Started: Oct 14, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06640088
Determining ICU Staffs Conceptions, Opinions, Views, Experiences and Reflection of Brain Death and Organ Donation
N/ARecruiting
200 participants
Started: Oct 14, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06630000
Focused Acceptance and Commitment Therapy (FACT)
NARecruiting
80 participants
Started: Oct 14, 2024 · Completed: Jan 1, 2027
1 condition2 sponsors1 location
NCT06657534
SISIPUSH: Evaluation of Hemolysis and Iatrogenic Anemia Using the Push-pull Method to Obtain Blood from Pediatric Patients with Central Venous Catheters
NARecruiting
150 participants
Started: Oct 14, 2024 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT06646679
Intelligent Segmentation Algorithm of Ultrasonic Image
N/ARecruiting
5,000 participants
Started: Oct 14, 2024 · Completed: Nov 14, 2026
1 condition1 sponsor1 location
NCT06629844
Enhancing Healthcare Students' Attitudes Toward Dementia Care Through Virtual Reality Education
NANot yet recruiting
200 participants
Started: Oct 14, 2024 · Completed: May 25, 2025
2 conditions2 sponsors1 location
NCT05690841
FocaL Mass Drug Administration for Vivax Malaria Elimination
PHASE3Recruiting
7,530 participants
Started: Oct 14, 2024 · Completed: May 1, 2027
2 conditions7 sponsors1 location
NCT06640439
LED Therapy for Third Molar Surgery
EARLY_PHASE1Not yet recruiting
50 participants
Started: Oct 14, 2024 · Completed: Apr 14, 2025
4 conditions1 sponsor1 location
NCT07135128
A Clinical Study of [225Ac]Ac-FAPI-XT(XT117) Injection in Patients With Advanced Solid Tumors
PHASE1Recruiting
20 participants
Started: Oct 14, 2024 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT06473961
A Phase Ⅰb Study on Autologous GC101 TIL Injection for the Treatment of NSCLC
PHASE1Recruiting
20 participants
Started: Oct 14, 2024 · Completed: Jul 1, 2027
2 conditions1 sponsor1 location
NCT06023459
Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR)
PHASE3Recruiting
144 participants
Started: Oct 14, 2024 · Completed: Feb 28, 2026
3 conditions11 sponsors7 locations
NCT07184684
Sinonasal Microbiome Transplant as a Therapy for Chronic Rhinosinusitis (CRS).
PHASE2/PHASE3Recruiting
50 participants
Started: Oct 14, 2024 · Completed: Feb 28, 2031
2 conditions1 sponsor1 location
NCT06453213
Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy
PHASE4Recruiting
90 participants
Started: Oct 14, 2024 · Completed: Jul 9, 2027
1 condition1 sponsor40 locations
NCT06451185
Statseal® for Central Venous Catheter Insertion Sites in Critical Care
NAActive, not recruiting
450 participants
Started: Oct 14, 2024 · Completed: Nov 30, 2025
5 conditions2 sponsors1 location
NCT06807788
Evaluation of Platelet Aggregability in Patients with Takayasu's Arteritis
N/AActive, not recruiting
100 participants
Started: Oct 14, 2024 · Completed: Oct 14, 2027
2 conditions1 sponsor1 location
NCT06668987
A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Recurrent Meningioma
PHASE1/PHASE2Active, not recruiting
10 participants
Started: Oct 14, 2024 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06634654
An Artificial Intelligence-based Approach in Total Knee Arthroplasty: From Inflammatory Responses to Personalized Medicine
NARecruiting
197 participants
Started: Oct 14, 2024 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT06349512
68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer (FAP-IT)
NARecruiting
60 participants
Started: Oct 14, 2024 · Completed: Nov 30, 2032
1 condition1 sponsor6 locations
NCT06693063
Impact of General Practice Follow-up on Emergency Hospitalization of Patients Admitted for Chest Pain
N/ARecruiting
100 participants
Started: Oct 14, 2024 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT06679270
Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
PHASE3Recruiting
15 participants
Started: Oct 14, 2024 · Completed: Mar 31, 2028
1 condition1 sponsor6 locations
NCT07152106
Amniotic Fluid & the Preterm Gut
N/ARecruiting
275 participants
Started: Oct 14, 2024 · Completed: Oct 14, 2027
8 conditions1 sponsor2 locations
NCT07217483
The Feasibility of Cream for Treatment of Neonatal Hypoglycemia
NARecruiting
75 participants
Started: Oct 14, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06616454
The Effect of Time-Restricted Feeding on Body Composition and Some Metabolic Parameters in Obese Adolescents
NARecruiting
60 participants
Started: Oct 14, 2024 · Completed: Aug 15, 2025
1 condition2 sponsors1 location
NCT04482140
Post Approval Study to Evaluate the Safety and Performance of GENTA-FOIL Resorb® in Hand Surgery
N/ARecruiting
55 participants
Started: Oct 14, 2024 · Completed: Oct 30, 2026
1 condition3 sponsors3 locations
NCT06852144
PET-TC in Thyroid Evaluation
N/AEnrolling by invitation
418 participants
Started: Oct 14, 2024 · Completed: Apr 30, 2029
3 conditions1 sponsor1 location
NCT06827145
Combination of Vebreltinib and Osimertinib in Patients with EGFR 21 L858R Mutation Advanced NSCLC
PHASE2Active, not recruiting
30 participants
Started: Oct 14, 2024 · Completed: Sep 30, 2028
1 condition2 sponsors1 location
NCT06083688
Preventing Malaria in School Children to Protect the Whole Community in Rural Blantyre District, Malawi
PHASE4Recruiting
1,000 participants
Started: Oct 14, 2024 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT06533813
Clinical Epidemiology in Contemporary Patients With Myelofibrosis.
N/ARecruiting
617 participants
Started: Oct 14, 2024 · Completed: Dec 31, 2028
1 condition2 sponsors36 locations
NCT06651762
Ultra Sound Guided Genicular Nerves Cooled Radiofrequency Ablation in Total Knee Replacement Surgeries
NARecruiting
66 participants
Started: Oct 14, 2024 · Completed: Jun 13, 2025
1 condition1 sponsor1 location
NCT06636539
Prospective Case Collection Study of Contrast-Enhanced Mammography Imaging Acquired on a New Investigational Device
NARecruiting
75 participants
Started: Oct 14, 2024 · Completed: Mar 31, 2026
1 condition1 sponsor2 locations
NCT06565247
Evaluation of PSMA-PET and mpMRI in High-risk Prostate Cancer - Using Histopathologic Validation
PHASE3Recruiting
60 participants
Started: Oct 14, 2024 · Completed: Dec 31, 2031
1 condition4 sponsors2 locations
NCT06486454
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
N/ARecruiting
5,000 participants
Started: Oct 14, 2024 · Completed: Nov 30, 2031
5 conditions1 sponsor21 locations
NCT06258707
Bicentric Clinical Investigation to Assess Safety and Performance of LuxBoost IOL
NARecruiting
58 participants
Started: Oct 14, 2024 · Completed: Dec 15, 2026
1 condition1 sponsor2 locations
NCT06676839
Effectiveness of the WHO ICOPE (Integrated Care for Older People) Program in Preventing Age-related Functional Decline (ICOPE Trial.Fr)
NARecruiting
1,000 participants
Started: Oct 14, 2024 · Completed: Oct 31, 2031
1 condition1 sponsor6 locations
NCT06279013
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment
NARecruiting
600 participants
Started: Oct 14, 2024 · Completed: May 1, 2028
2 conditions1 sponsor34 locations
NCT06883227
Investigating Health Impacts of Exposure to Harmful Algal Blooms
N/ARecruiting
400 participants
Started: Oct 14, 2024 · Completed: Oct 14, 2030
3 conditions1 sponsor1 location
NCT06424249
Dynamic Balance in Unilateral Transtibial Amputees Following Virtual Reality Versus Conventional Rehabilitation
NARecruiting
20 participants
Started: Oct 14, 2024 · Completed: Jun 30, 2026
3 conditions1 sponsor2 locations
NCT06495372
Study of the Use of Methoxyflurane vs Placebo in the Management of Pain in Oral and Dental Emergencies in Adults: METODO (METhoxyflurane in ODOntology)
PHASE3Recruiting
192 participants
Started: Oct 14, 2024 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT06736054
A Phase I Trial of 61Cu-NODAGA-PSMA for Patients with Prostate Cancer
PHASE1Recruiting
8 participants
Started: Oct 14, 2024 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT06533332
A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors
PHASE1Recruiting
15 participants
Started: Oct 14, 2024 · Completed: Jun 30, 2026
6 conditions1 sponsor4 locations
NCT06888167
Food (poly)phenol Metabotypes and Beta-cell Mass and Function.
NARecruiting
40 participants
Started: Oct 14, 2024 · Completed: Feb 28, 2026
1 condition2 sponsors1 location
NCT06515223
Improving Pelvic Rehabilitation Using Epidural Stimulation After Spinal Cord Injury
NARecruiting
20 participants
Started: Oct 14, 2024 · Completed: Nov 1, 2027
5 conditions2 sponsors1 location
NCT06189352
Positive Feeding of the Preterm Infant
NARecruiting
15 participants
Started: Oct 14, 2024 · Completed: May 31, 2026
6 conditions1 sponsor1 location
NCT06545916
Study of Sunobinop on Alcohol Consumption in Alcohol Use Disorder
PHASE2Recruiting
200 participants
Started: Oct 14, 2024 · Completed: Mar 31, 2026
1 condition2 sponsors7 locations
NCT06345079
Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours
PHASE2Recruiting
78 participants
Started: Oct 14, 2024 · Completed: Jun 30, 2028
1 condition2 sponsors12 locations
NCT06558799
LUNAR-4: Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Pembrolizumab for Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC)
PHASE2Recruiting
69 participants
Started: Oct 14, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor24 locations
NCT06562296
Study Evaluating Several CAMPs in Nonhealing Diabetic Foot and Venous Leg Ulcers
PHASE4Active, not recruiting
292 participants
Started: Oct 14, 2024 · Completed: Dec 25, 2025
2 conditions3 sponsors4 locations
NCT06585449
A Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's Disease
PHASE1Recruiting
54 participants
Started: Oct 14, 2024 · Completed: Jul 5, 2028
1 condition1 sponsor17 locations